NCT04971733 2025-06-10A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's DiseaseEisai Inc.Phase 1/2 Completed8 enrolled 21 charts
NCT01083316 2020-09-25Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) AmyloidosisBoston Medical CenterPhase 2 Completed35 enrolled 9 charts
NCT02767609 2019-04-30Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance ImagingLoma Linda UniversityPhase NA Completed1 enrolled 4 charts
NCT00428090 2017-05-19Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseGlaxoSmithKlinePhase 3 Completed862 enrolled 36 charts